跳到主要內容

Kim Lorence H. 的 Form 4 申報

Revolution Medicines, Inc.(RVMD),2026/9/10 申報

申報編號
0001193125-26-388156
申報時間
2026/9/10 17:52 ET
交易日
2026/9/8
申報延遲
2 天
10b5-1 計畫
有勾選

這份申報列了 7 筆非衍生性交易。公開市場賣出合計 $358.6 萬。交易後 2 天申報。

申報人

一份 Form 4 可以有好幾位申報人,例如本人與他控制的基金。各交易表上顯示的是第一位。

這份申報的申報人
申報人與公司的關係
Kim Lorence H.CIK 0001643746董事

非衍生性證券(表 I)

普通股等股票的取得與處分,每一列是申報上的一筆。

非衍生性證券的交易
交易日證券交易股數價格金額交易後持股持有方式旗標
2026/9/8Common StockS賣出處分−706$206.60F3−$145,863.0616,384間接
2026/9/8Common StockS賣出處分−999$207.33F5−$207,124.7715,385間接
2026/9/8Common StockS賣出處分−3,587$208.55F6−$748,081.0511,798間接
2026/9/8Common StockS賣出處分−2,853$209.56F7−$597,874.688,945間接
2026/9/8Common StockS賣出處分−4,730$210.50F8−$995,678.244,215間接
2026/9/8Common StockS賣出處分−3,844$211.36F9−$812,463.23371間接
2026/9/8Common StockS賣出處分−371$212.27F10−$78,751.910間接

附註與備註

本站收錄交易價格引用的附註、修正申報(Form 4/A)的全部附註,以及申報的備註。其他附註,例如間接持有的方式、交易計畫的細節,請看 SEC EDGAR 上的原文。

F3

The transaction was executed in multiple trades at prices ranging from $206.47 to $206.9903, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

表 I 有 1 筆交易的價格引用這則附註。

F5

The transaction was executed in multiple trades at prices ranging from $207.02 to $207.70, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

表 I 有 1 筆交易的價格引用這則附註。

F6

The transaction was executed in multiple trades at prices ranging from $208.05 to $208.96, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

表 I 有 1 筆交易的價格引用這則附註。

F7

The transaction was executed in multiple trades at prices ranging from $209.08 to $209.9809, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

表 I 有 1 筆交易的價格引用這則附註。

F8

The transaction was executed in multiple trades at prices ranging from $210.0114 to $210.97, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

表 I 有 1 筆交易的價格引用這則附註。

F9

The transaction was executed in multiple trades at prices ranging from $211.00 to $211.9425, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

表 I 有 1 筆交易的價格引用這則附註。

F10

The transaction was executed in multiple trades at prices ranging from $212.0775 to $212.3903, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

表 I 有 1 筆交易的價格引用這則附註。

看 SEC EDGAR 上的完整原文 (在新分頁開啟)